Content change #7

_data/sidebars/framework.yml

@@ -40,7 +40,7 @@ subitems:
   - title: Genomics into healthcare
     image_url: /assets/img/section-icons/genomics-into-healthcare.svg
     url: /genomics-into-healthcare
-    description: Self-assessment maturation model to guide health care systems on their journey to deploy genomic medicine.
+    description: Assessment Maturity Level Model to guide healthcare systems on their journey to implement genomic medicine.
 
   - title: Use cases
     image_url: /assets/img/section-icons/use-case.svg

_data/sidebars/trust_framework2.yml

@@ -9,7 +9,7 @@ subitems:
   - title: Genomics into healthcare
     image_url: /assets/img/section-icons/genomics-into-healthcare.svg
     url: /genomics-into-healthcare
-    description: Self-assessment maturation model to guide health care systems on their journey to deploy genomic medicine.     
+    description: Assessment maturation model to guide health care systems on their journey to deploy genomic medicine.     
 
   - title: National resources
     image_url: /assets/img/section-icons/nation.svg

pages/about/about-the-framework.md

@@ -4,7 +4,7 @@ title: About the Framework
 
 ## Intro to 1+MG, B1MG, and GDI
 
-The [1+ Million Genomes (1+MG) initiative](https://digital-strategy.ec.europa.eu/en/policies/1-million-genomes) aims to enable secure access to genomics and the corresponding clinical data across Europe for better research, personalised healthcare and health policy making. Since the Digital Day 2018, 24 EU countries, the United Kingdom and Norway signed the Member States’ Declaration ‘Towards access to at least 1 million sequenced genomes in the EU by 2022’ that consists of stepping up efforts towards creating a European data infrastructure for genomic data and implementing common national rules enabling federated data access. The initiative forms part of the EU’s agenda for the Digital Transformation
+The [1+ Million Genomes (1+MG) initiative](https://digital-strategy.ec.europa.eu/en/policies/1-million-genomes) aims to enable secure access to genomics and the corresponding clinical data across Europe for better research, personalised healthcare and health policy making. Since the Digital Day 2018, 24 EU countries plus the United Kingdom and Norway signed the Member States’ Declaration ‘Towards access to at least 1 million sequenced genomes in the EU by 2022. This plan consists of stepping up efforts towards creating a European data infrastructure for genomic data and implementing common national rules enabling federated data access. The initiative forms part of the EU’s agenda for the Digital Transformation
 of Health and Care and is aligned with the goals of the European Health Data Space (EHDS). The 1+MG Roadmap, published in February 2020, sets out the priorities for the period 2020-2022.
 
 The [Beyond 1 Million Genomes (B1MG)](https://b1mg-project.eu/) project is helping to create a network of genetic and clinical data across Europe. The project provides coordination and support to the 1+ Million Genomes Initiative (1+MG). This initiative is a commitment of 24 EU countries, the UK and Norway to give cross-border access to one million sequenced genomes by 2022.  But B1MG will go 'beyond' the 1+MG Initiative by creating long-term means of sharing data beyond 2022, and enabling access to beyond 1 million genomes. 
@@ -25,6 +25,7 @@ It will contain the set of agreed outputs and guidance on:
 * Data standards to be applied to fulfil FAIR principles
 * Technical Infrastructure standards and APIs to be implemented
 * Data quality guidelines
+* Tools and guideance for Node and country advancement
 
 
 <img src="{{ 'assets/img/realising-vision-for-european-healthcare.png' | relative_url }}" class="m-2" style="max-width: 100%; max-height: 100%; vertical-align: middle" alt="Realising vision for European Healthcare" />

pages/genomics-into-healthcare.md

@@ -4,18 +4,17 @@ description: Implementation of Genomics into Healthcare
 page_id: healthcare
 ---
 
-The implementation of Genomic medicine in healthcare systems will bring us closer to making personalised medicine a reality, with major socioeconomic benefits. 
+The implementation of genomic medicine in healthcare systems will bring us closer to making personalised medicine a reality, with major socioeconomic benefits.
 
-Citizens and patients can nowadays widely benefit from genomic data analysis for accurate and timely diagnosis, more effective treatments with less adverse events and, in the near future, accurate profiling for disease prevention.
-
-Implementation of genomics in healthcare is complex and requires adjustments in the governance, structure and organization of health services, as well as dedicated investments. Implementation is also dependent on the country context.
+Citizens and patients can nowadays widely benefit from genomic data analysis for accurate and timely diagnosis, more effective treatments with fewer adverse events and, in the near future, accurate profiling for disease prevention.  
+Implementation of genomics in healthcare is complex and requires adjustments in the governance, structure and organisation of health services, as well as dedicated investments. Moreover, the progress of implementation varies with country context.
 
-Promoting dialogue and cooperation among countries, for capacity building and sharing of best practices, is key to promoting equity in access to PM across Europe.
+Facilitating dialogue and cooperation among countries for capacity building and sharing of best practices is key to promoting equity in access to Personal Medicine across Europe.
 
-To fully exploit the potential of genomic information to benefit citizens health, it is crucial to understand how effectively healthcare systems implement genomic medicine. In the context of the 1+ Million Genomes Initiative (1+MG), we developed a Maturity Level Model (MLM) for health systems to self-evaluate the maturity of their genomic medicine practices, and define a path to optimization.
+To fully exploit the potential of genomic information to benefit citizens health, it is crucial to understand how effectively healthcare systems implement genomic medicine. In the context of the 1+ Million Genomes Initiative (1+MG), a Maturity Level Model (MLM) was developped for healthcare systems to evaluate the maturity of their genomic medicine practices, and define a path to optimization.
 
 
-<img src="{{ 'assets/img/1+mg-roadmap.png' | relative_url }}" class="m-2" style="max-width: 100%; max-height: 100%; vertical-align: middle" alt="1+MG Roadmap" />
+<img src="{{ 'assets/img/1+mg-roadmap.png' | relative_url }}" class="m-2" style="max-width: 80%; max-height: 100%; vertical-align: middle" alt="1+MG Roadmap" />
 
 ## Maturity Level Model